Grape King Bio Statistics

Total Valuation

Grape King Bio has a market cap or net worth of TWD 20.15 billion. The enterprise value is 18.30 billion.

Market Cap	20.15B
Enterprise Value	18.30B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Jun 23, 2025

Share Statistics

Grape King Bio has 148.14 million shares outstanding. The number of shares has decreased by -0.15% in one year.

Current Share Class	148.14M
Shares Outstanding	148.14M
Shares Change (YoY)	-0.15%
Shares Change (QoQ)	-0.97%
Owned by Insiders (%)	12.23%
Owned by Institutions (%)	21.53%
Float	115.07M

Valuation Ratios

The trailing PE ratio is 14.49.

PE Ratio	14.49
Forward PE	n/a
PS Ratio	1.82
PB Ratio	1.75
P/TBV Ratio	2.11
P/FCF Ratio	16.72
P/OCF Ratio	11.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.17, with an EV/FCF ratio of 15.19.

EV / Earnings	13.09
EV / Sales	1.65
EV / EBITDA	6.17
EV / EBIT	7.43
EV / FCF	15.19

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.02.

Current Ratio	1.64
Quick Ratio	1.37
Debt / Equity	0.02
Debt / EBITDA	0.08
Debt / FCF	0.20
Interest Coverage	736.37

Financial Efficiency

Return on equity (ROE) is 17.91% and return on invested capital (ROIC) is 12.71%.

Return on Equity (ROE)	17.91%
Return on Assets (ROA)	9.99%
Return on Invested Capital (ROIC)	12.71%
Return on Capital Employed (ROCE)	20.66%
Revenue Per Employee	22.09M
Profits Per Employee	2.79M
Employee Count	501
Asset Turnover	0.72
Inventory Turnover	3.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.95% in the last 52 weeks. The beta is 0.48, so Grape King Bio's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-14.95%
50-Day Moving Average	140.00
200-Day Moving Average	146.00
Relative Strength Index (RSI)	47.14
Average Volume (20 Days)	141,136

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Grape King Bio had revenue of TWD 11.06 billion and earned 1.40 billion in profits. Earnings per share was 9.38.

Revenue	11.06B
Gross Profit	8.55B
Operating Income	2.44B
Pretax Income	2.60B
Net Income	1.40B
EBITDA	2.89B
EBIT	2.44B
Earnings Per Share (EPS)	9.38

Full Income Statement

Balance Sheet

The company has 3.95 billion in cash and 244.83 million in debt, giving a net cash position of 3.71 billion or 25.02 per share.

Cash & Cash Equivalents	3.95B
Total Debt	244.83M
Net Cash	3.71B
Net Cash Per Share	25.02
Equity (Book Value)	11.53B
Book Value Per Share	65.18
Working Capital	2.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.78 billion and capital expenditures -570.93 million, giving a free cash flow of 1.21 billion.

Operating Cash Flow	1.78B
Capital Expenditures	-570.93M
Free Cash Flow	1.21B
FCF Per Share	8.14

Full Cash Flow Statement

Margins

Gross margin is 77.28%, with operating and profit margins of 22.05% and 12.64%.

Gross Margin	77.28%
Operating Margin	22.05%
Pretax Margin	23.51%
Profit Margin	12.64%
EBITDA Margin	26.11%
EBIT Margin	22.05%
FCF Margin	10.89%

Dividends & Yields

This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 5.04%.

Dividend Per Share	6.90
Dividend Yield	5.04%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	101.72%
Buyback Yield	0.15%
Shareholder Yield	5.19%
Earnings Yield	6.94%
FCF Yield	5.98%

Dividend Details

Stock Splits

The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.

Last Split Date	Sep 15, 2005
Split Type	Forward
Split Ratio	1.0205

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a